Latest news with #Holzer&Holzer
Associated Press
28-03-2025
- Business
- Associated Press
INVESTOR ALERT: Investigation of Pony AI Inc. (PONY) Announced by Holzer & Holzer, LLC
ATLANTA, March 28, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Pony AI Inc. ('Pony AI' or the 'Company') (NASDAQ: PONY) complied with federal securities laws. On March 25, 2025, Pony AI announced unaudited fourth quarter and full year 2024 financial results, revealing a decrease in robotaxi services revenue for the fourth quarter. The Company said the 'decrease was mainly driven by reduced service fees from providing autonomous vehicle engineering solutions based on our collaboration projects' progression schedule.' Following this news, the price of the Company's stock dropped. If you purchased Pony AI stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at to discuss your legal rights. Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. Corey Holzer, Esq. (888) 508-6832 (toll-free)
Associated Press
28-03-2025
- Business
- Associated Press
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of Actinium Pharmaceuticals, Inc. (ATNM) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
ATLANTA, March 28, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Actinium Pharmaceuticals, Inc. ('Actinium' or the 'Company') (NYSE: ATNM). The lawsuit alleges that Defendants made materially false and/or misleading statements, and/or failed to disclose material adverse facts, including allegations that: (i) Actinium 'repeatedly touted the Sierra Trial's positive DCR data while downplaying the study's failure to generate statistically significant or clinically meaningful Overall Survival data; and (ii) misled investors about the importance of the Sierra Trial's poor Overall Survival data by claiming that the FDA had somehow blessed the design of the Sierra Trial such that the lack of statistically significant or clinically meaningful OS data would not be a barrier to approval of the BLA.' If you bought shares of Actinium between October 31, 2022 and August 2, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm's website at to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is May 26, 2025. Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. Corey Holzer, Esq.
Associated Press
25-03-2025
- Business
- Associated Press
INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC
ATLANTA, March 25, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether CorMedix Inc. ('CorMedix' or the 'Company') (NASDAQ: CRMD) complied with federal securities laws. On March 25, 2025, Cormedix reported fourth quarter and full year 2024 financial results. During the Company's earnings call held the same day, Cormedix noted that 'we do expect to begin to see some net price erosion beginning in the second quarter of 2025.' Following this news, the price of the Company's stock dropped. If you purchased CorMedix stock and suffered a loss on that investment, you are encouraged to contact Corey Holzer, Esq. at [email protected] or Joshua Karr, Esq. at [email protected], call our toll-free number at (888) 508-6832, or visit our website at to discuss your legal rights. Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. Corey Holzer, Esq.
Associated Press
18-03-2025
- Business
- Associated Press
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of The Bancorp, Inc. (TBBK) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
ATLANTA, March 18, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against The Bancorp, Inc. ('Bancorp' or the 'Company') (NASDAQ: TBBK). The lawsuit alleges that Defendants made false and/or misleading statements, as well as failed to disclose material facts regarding Bancorp's business, operations, and prospects, including allegations that: (1) Bancorp had underrepresented the significant risk of default or loss on its REBL loan portfolio; (2) Bancorp's current expected credit loss methodology was insufficient to account for the provision and/or allowance of credit losses; (3) as a result of the foregoing, Bancorp was reasonably likely to increase its provision for credit losses; (4) there was material weakness in its internal control over financial reporting; (5) its financial statements had not been approved by its independent auditor; and (6) as a result of the foregoing, the Company's financial statements could not be relied upon. If you bought shares of Bancorp between January 25, 2024 and March 4, 2025, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm's website at to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is May 16, 2025. Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. Corey Holzer, Esq.
Associated Press
18-02-2025
- Business
- Associated Press
INVESTOR ALERT: Class Action Lawsuit Filed on Behalf of TransMedics Group, Inc. (TMDX) Investors – Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the Firm
ATLANTA, Feb. 18, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against TransMedics Group, Inc. ('TransMedics' or the 'Company') (NASDAQ: TMDX). The lawsuit alleges that Defendants made materially false and/or misleading statements and/or failed to disclose material adverse facts about TransMedics's business, operations, and prospects, including allegations that: (1) TransMedics used kickbacks, fraudulent overbilling, and coercive tactics to generate business and revenue; (2) TransMedics engaged in unsafe practices and hid safety issues and generally lacked safety oversight; and (3) the foregoing subjected TransMedics to heightened risk of scrutiny and regulatory risk. If you bought shares of TransMedics between February 28, 2023 and January 10, 2025, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at [email protected], by toll-free telephone at (888) 508-6832 or you may visit the firm's website at to learn more. The deadline to ask the court to be appointed lead plaintiff in the case is April 15, 2025. Holzer & Holzer, LLC, an ISS top rated securities litigation law firm for 2021, 2022, and 2023, dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide, including shareholder class action and derivative litigation. Since its founding in 2000, Holzer & Holzer attorneys have played critical roles in recovering hundreds of millions of dollars for shareholders victimized by fraud and other corporate misconduct. More information about the firm is available through its website, and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey Holzer is the attorney responsible for its content. Corey Holzer, Esq. (888) 508-6832 (toll-free)
